Clinical trial

Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder…

NCT00202449 · Seattle Institute for Biomedical and Clinical Research, Other · Terminated

Key facts

NCT number NCT00202449
Title Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance
Official title A Placebo-Controlled Trial of Prazosin vs. Paroxetine in Combat Stress-Related PTSD Nightmares and Sleep Disturbance
Lead sponsor Seattle Institute for Biomedical and Clinical Research, Other
Collaborators United States Department of Defense U.S. Fed VA Puget Sound Health Care System
Status Terminated
Study type Interventional
Conditions Stress Disorders, Post-Traumatic, Sleep Disorders
Intervention type Drug
Interventions prazosin, paroxetine, Placebo
Enrollment 59
Start date Jul 1, 2004
Primary completion Feb 1, 2008
Completion Feb 1, 2008
First posted Sep 20, 2005
Last update posted Jul 10, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies